Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|April 14, 2010
Pharmacokinetics and pharmacodynamics of propiverine in children aged between 5 and 10 years with symptoms of overactive bladderWerner Siegmund, Ulla Sillén, Göran Läckgren, et al.
The Journal of Urology|May 1, 2004
An empirical treatment algorithm for incontinent childrenArne-Daniela Marschall-Kehrel, Gerd Mürtz, Guus Kramer, et al.
BJU International|January 25, 2006
Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysisHeinrich Schulte-Baukloh, Gerd Mürtz, Thomas Henne, et al.
European Urology|June 22, 2005
Propiverine versus tolterodine: efficacy and tolerability in patients with overactive bladderKlaus-Peter Jünemann, Michael Halaska, Tomas Rittstein, et al.
BJU International|January 22, 2009
Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomesSaladin Helmut Alloussi, Gerd Mürtz, Silvia Gitzhofer, et al.
Journal of Pediatric Urology|September 13, 2011
Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term studyHeinrich Schulte-Baukloh, Gerd Mürtz, Gert Heine, et al.
Pageof 1